Purchase Order 75N91018P00738
Award Date 9/17/18
Potential Completion Date 4/17/19
Potential Value $243K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Cincinnati, OH 45229, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Children's Hospital Medical Center, doing business as Children's Home Healthcare, was awarded a $21,450 purchase order by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services. The firm fixed price contract is for laboratory testing services to support the NIH's research efforts. Performance will take place in Cincinnati, Ohio over a five-month period from August 1, 2023 through December 31, 2023. No subcontractors or...
- Childrens Hospital Medical Center, doing business as Children's Home Healthcare, was awarded a $258,310.00 firm-fixed-price purchase order by the National Cancer Institute (NCI), part of the Department of Health and Human Services' National Institutes of Health (NIH), to produce 20 liters of a clinical-grade, gamma-retroviral gene-therapy vector. This vector, to be generated using the transient transfection method, will encode a chimeric antigen receptor (CAR) recognizing a multiple myeloma...
- This is a federal contract award to Childrens Hospital Medical Center, a non-profit pediatric hospital and research center in Cincinnati, Ohio. The $1,334,309.94 contract is a delivery order under the NIAID Animal Models of Infectious Diseases 2010-2017 IDIQ contract with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The contract is for R&D - Medical: Biomedical (Basic Research) services and does not have a set-aside...
- The National Cancer Institute (NCI) awarded a $2,220,788.57 firm fixed price delivery order contract to the Research Institute at Nationwide Children's Hospital, a non-profit organization, to provide biospecimen core resource services in support of the Cancer Models Development Centers (CMDC) program. This delivery order contract is part of a larger Indefinite Delivery Contract between the Research Institute and the Department of Health and Human Services' Health Resources and Services...
- This is a $1,112,184.00 firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the Research Institute at Nationwide Children's Hospital, a non-profit research organization. The contract is for nucleic acid extractions and biospecimen core resource services to support studies conducted by NCI's Division of Cancer Epidemiology and Genetics (DCEG). The award has an ultimate completion date of August 31,...
- This is a firm fixed price delivery order contract awarded by the National Cancer Institute, a component of the Department of Health and Human Services, to the Research Institute at Nationwide Children's Hospital, a non-profit organization affiliated with Nationwide Children's Hospital in Columbus, Ohio. The $2,318,579.00 contract is part of the Biospecimen Core Resource - Early Onset Malignancies Initiative program and will provide research services to support the Early Onset Malignancies...
- This federal contract award to Childrens Hospital Medical Center, doing business as Children's Home Healthcare, is a $73,608.15 firm fixed-price delivery order under the National Institute of Allergy and Infectious Diseases (NIAID) Animal Models of Infectious Diseases 2010-2017 indefinite-delivery/indefinite-quantity (IDIQ) contract. The purpose of the task order is to conduct mouse model testing of a GSK GD-Alum/MPL vaccine. The contract has no set-aside designation. Childrens Hospital...
- This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to the Research Institute at Nationwide Children's Hospital, a non-profit organization. The $248,498.00 contract is for conducting nucleic acid extractions from biological samples to support cancer epidemiology research under the agency's Biospecimen Core Resource program. The award does not utilize any set-aside designation. The...
- The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) awarded a purchase order contract valued at one hundred twenty thousand six hundred dollars ($120,600) to Vector Biomed Inc. The contract is to obtain preclinical grade lentiviral vectors in support of NCI's Pediatric Oncology Branch investigational new drug enabling studies and demonstration of clinical-grade vector production feasibility. Services include receipt confirmation...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $51,750 firm-fixed-price purchase order to Childrens Hospital Medical Center, doing business as Children's Home Healthcare, a non-profit pediatric hospital and research center in Cincinnati, Ohio. The purpose of the contract is to provide natural killer (NK) cell function testing services to support post-acute sequelae of SARS-CoV-2 and Gulf War illness studies. This award was made on a non-competitive basis, as...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute (NCI) awarded a $243,100.71 firm fixed price purchase order to Childrens Hospital Medical Center (dba Children's Home Healthcare), a non-profit hospital located in Cincinnati, Ohio. The contract is for the production and biosafety testing of a current Good Manufacturing Practices (cGMP)-compliant transient gammaretroviral vector to be used in NCI clinical trials. The contract period of performance is 8 months for manufacturing and certification, followed by 3 one-year option periods for vector stability testing. No set-aside designation was used for this award.
Generated 3/21/24, 11:22 PM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Production and Biosafety Testing of cGMP (current Good Manufacturing Practices) - compliant Transient Gammaretroviral Vector for NCI Clinical Trials. | N02CO82606-95-1 | Department of Health and Human Services National Institutes of Health | Solicitation 1/1 | 8/15/18, 8:29 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $216.5k | 9/17/18 |